Olink

Olink®
Part of Thermo Fisher Scientific

Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients

Scientific Reports, 2022

Star B., Boahen C., van der Slikke E., Quinten V., ter Maaten J., Henning R., Kumar V., Bouma H.

Disease areaApplication areaSample typeProducts
Infectious Diseases
Nephrology
Pathophysiology
Patient Stratification
Plasma
Olink Target 96

Olink Target 96

Abstract

Acute kidney injury (AKI) develops frequently in the course of patients with sepsis and strongly associates with in-hospital mortality. However, diagnosing AKI involves a considerable lag-time because it depends on assessing an increase in serum creatinine, and offers no insight in the underlying pathophysiology. Consequently, identifying a set of proteins reflecting the development of AKI may improve earlier recognition of AKI and the understanding of its pathophysiology. A targeted plasma proteomic approach was performed in early sepsis patients with and without subsequent AKI development in a matched pair design (n = 19 each). Principal component analysis identified 53 proteins associated with development of AKI, which were further analysed using Enrichr gene ontology and pathway analysis. Nine differentially expressed proteins from the targeted proteomics were increased among patients who subsequently developed AKI and correlated with principal components, namely CALCA, CALR, CA12, CLEC1A, PTK7, KIM-1, NPPC, NUCB2 and PGF. We demonstrated the biological insight in the development of AKI in early sepsis compared to non-AKI sepsis.

Read publication ↗